RENUAC Trademark

Trademark Overview

On Friday, July 14, 2006, a trademark application was filed for RENUAC with the United States Patent and Trademark Office. The USPTO has given the RENUAC trademark a serial number of 78929648. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 18, 2015. This trademark is owned by Pfizer Inc.. The RENUAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of urological diseases and disorders
renuac

General Information

Serial Number78929648
Word MarkRENUAC
Filing DateFriday, July 14, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 18, 2015
Registration Number3578070
Registration DateTuesday, February 17, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of urological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 18, 2015
Primary Code005
First Use Anywhere DateWednesday, November 26, 2008
First Use In Commerce DateWednesday, November 26, 2008

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, September 18, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, February 17, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, January 13, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, January 8, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 8, 2009STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 23, 2008USE AMENDMENT FILED
Thursday, January 8, 2009EXTENSION 4 GRANTED
Tuesday, December 23, 2008EXTENSION 4 FILED
Tuesday, December 23, 2008TEAS EXTENSION RECEIVED
Tuesday, December 23, 2008TEAS STATEMENT OF USE RECEIVED
Monday, September 29, 2008EXTENSION 3 GRANTED
Thursday, September 25, 2008EXTENSION 3 FILED
Monday, September 29, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 25, 2008TEAS EXTENSION RECEIVED
Friday, April 4, 2008EXTENSION 2 GRANTED
Tuesday, March 18, 2008EXTENSION 2 FILED
Tuesday, March 18, 2008TEAS EXTENSION RECEIVED
Saturday, September 29, 2007EXTENSION 1 GRANTED
Friday, September 7, 2007EXTENSION 1 FILED
Friday, September 7, 2007TEAS EXTENSION RECEIVED
Tuesday, April 3, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2007PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2006NOTICE OF PUBLICATION
Tuesday, November 21, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 9, 2006ASSIGNED TO LIE
Friday, November 3, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 2, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, November 2, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, November 2, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, November 2, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, October 2, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, September 7, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 1, 2006ASSIGNED TO LIE
Wednesday, August 30, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 24, 2006ASSIGNED TO EXAMINER
Wednesday, July 19, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

renuac diseases disorders urological treatment preparations pharmaceutical